Guggenheim Capital LLC Dynavax Technologies Corp Transaction History

Guggenheim Capital LLC

$12 Billion
Q4 2024

A detailed history of Guggenheim Capital LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Guggenheim Capital LLC holds 47,069 shares of DVAX stock, worth $627,429. This represents 0.01% of its overall portfolio holdings.

Number of Shares

47,069

Previous 70,098 32.85%

Holding current value

$627,429

Previous $780,000 22.95%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$10.28 - $13.66 $236,738 - $314,576	-23,029 Reduced 32.85%	47,069 $601,000
Q3 2024 Nov 13, 2024	BUY	$10.05 - $11.61 $42,672 - $49,296	4,246 Added 6.45%	70,098 $780,000
Q2 2024 Aug 14, 2024	SELL	$10.73 - $12.58 $550,051 - $644,888	-51,263 Reduced 43.77%	65,852 $739,000
Q1 2024 May 14, 2024	BUY	$11.7 - $14.98 $9,149 - $11,714	782 Added 0.67%	117,115 $1.45 Million
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $754,049 - $862,922	57,605 Added 98.09%	116,333 $1.63 Million
Q3 2023 Nov 14, 2023	BUY	$12.64 - $14.99 $86,369 - $102,426	6,833 Added 13.17%	58,728 $867,000
Q2 2023 Aug 11, 2023	BUY	$9.85 - $13.17 $357,200 - $477,596	36,264 Added 232.0%	51,895 $670,000
Q1 2023 May 10, 2023	SELL	$9.44 - $11.88 $103,094 - $129,741	-10,921 Reduced 41.13%	15,631 $153,000
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $7,723 - $9,994	752 Added 2.91%	26,552 $282,000
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $289,846 - $509,056	-29,189 Reduced 53.08%	25,800 $269,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $409,668 - $705,508	54,989 New	54,989 $692,000
Q4 2018 Feb 14, 2019	SELL	$8.14 - $13.28 $1.13 Million - $1.84 Million	-138,719 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.85 - $16.0 $229,688 - $310,128	19,383 Added 16.24%	138,719 $1.72 Million
Q2 2018 Aug 14, 2018	BUY	$15.15 - $20.75 $106,928 - $146,453	7,058 Added 6.29%	119,336 $1.82 Million
Q1 2018 May 15, 2018	BUY	$14.65 - $19.9 $110,197 - $149,687	7,522 Added 7.18%	112,278 $2.23 Million
Q4 2017 Feb 14, 2018	SELL	$17.3 - $24.08 $74,095 - $103,134	-4,283 Reduced 3.93%	104,756 $1.96 Million
Q3 2017 Nov 14, 2017	BUY	$15.2 - $21.5 $1.66 Million - $2.34 Million	109,039	109,039 $2.35 Million

Others Institutions Holding DVAX

# of Institutions

288

Shares Held

131M

Call Options Held

507K

Put Options Held

374K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.69B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Dynavax Technologies Corp Transaction History